2023 HHOW Pediatric Cancer Research Funding - Young Investigator Grant

No applicants // Limit: 1 // Tickets Available: 1 

The intent of the HHOW pediatric cancer research grants is to provide funding for principal investigators (herein referred to as “PI”), whose research projects are likely to have a significant impact on improving the understanding of the biology of childhood cancer and/or developing novel diagnostic, prognostic, and therapeutic approaches for pediatric malignancies. The grants are awarded to the institution for the benefit of the research of the approved projects. Projects eligible to be funded by this program will be those that pursue innovative research that is translational in nature, that is, has the potential to impact childhood cancer diagnosis and treatment. Proposals requesting support for clinical trials are not eligible for consideration.

Funding for the Grants is awarded to the applying institution (herein referred to as the applicant) for the purpose of supporting the PI and the research specified in the proposal. Submitting PIs must include a letter of support from the division chief of pediatric oncology at the applicant institution, and concurrence of the development office. With the submission of the Grant application(s), the PI(s) confirm(s) that each is authorized by the officers of the institution to submit the application and the institution agrees to abide by all terms and conditions of the grant.

The funds of awarded grants may not be transferred to a different institution under any circumstance, should the designated PI leave the institution for any reason.However, the institution may nominate a new qualified candidate to serve as the PI, subject to the new candidate meeting all guidelines and with no substantive changes to the approved project.

2023 HYUNDAI YOUNG INVESTIGATOR GRANT
The Hyundai Young Investigator’s Grant is a $200,000 grant, which will be provided as $100,000 per year grant for years 1 and 2.
Eligible Criteria for Young Investigator:

1. PI must be an MD or MD/PhD who is currently in his/her 3rd or 4th year of an accredited pediatric hematology-oncology fellowship training program and involved in pediatric cancer research; or
2. Must be a pediatric oncologist/MD, or MD/PhD in his/her initial academic appointment, within 6 years from completion of fellowship training, and involved in pediatric cancer research.
3. A PhD is not eligible to be a PI, for the purposes of the award, but may participate as a member of a research team.

Research proposals will be evaluated based on:

1. Relevance to pediatric cancer
2. Quality of science
3. Innovation
4. Potential for success
5. Potential impact on the field
6. Quality of applicant
7. Quality of institutional environment
8. Demonstrated need for funding

• Only ONE proposal in each category (i.e. one Young Investigator and one Scholar Hope may be submitted from any individual Applicant), for a total of TWO per institution.
• A PI may apply in either category, but not both. An applying PI may not have two HHOW grants at the same time. If the PI is a current HHOW grant awardee, they may not apply for a second HHOW grant award until the second year of their current award.
• Grant funds may be used to support bench or translational research and must have a direct relevance to pediatric cancer. 
• Less than 10% of funds can be used for indirect costs and no funds can be used for fringe benefits through the Scholar Hope or Young Investigator Grants.
• Applicants may use funds in conjunction with another award on the same topic. However, the difference has to be clearly identified in the budget.
• If Applicant has submitted multiple applications to other foundations or granting agencies, for funding the same project  concurrently, HHOW must be notified in the written application (Section VII below)
• The PI for either the Young Investigator or Hope Scholar award may not have more than 1 RO1 or RO1-equivalent at the time of application. K awards or equivalent are permitted for Young Investigator and Scholar PIs.